— Know what they know.
Not Investment Advice

EAPH OTC

Parallel Industries Inc.
1W: -95.0% 1M: -95.0% 3M: +0.0% YTD: +0.0% 1Y: -90.0% 3Y: -99.0% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $26899 mcap · 1.24B float · 0.0053% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume1,000
Avg Volume65,895
Beta-8.88
Dividend—
Analyst Ratings
2 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOEvan Karras
Employees6
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1999-09-13
111 Brockhouse Road
Toronto, ON
CA
About Parallel Industries Inc.

Currently, Parallel Industries Inc. does not conduct substantial business operations. Historically, the company was involved in developing and commercializing various topically applied medications to treat cancer, alongside other therapeutic solutions for a range of medical conditions. Its strategic emphasis has typically covered the entire pharmaceutical process: from development and licensing to manufacturing and marketing of both prescription and over-the-counter products. Established in 1997, the firm is headquartered in Toronto, Canada, and was formerly known as Easton Pharmaceuticals Inc. before rebranding as Parallel Industries Inc. in December 2020.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms